logo

For the Inventor, By the Inventor

Bottmingen, Switzerland

Richard Berthold

USPTO Granted Patents = 19

Average Co-Inventor Count = 1.6

ph-index = 6

Forward Citations = 98(Granted Patents)


Location History:

  • Bottmingen, CH (1977 - 1990)
  • Bottringen, CH (1990)
  • CH-4103 Bottmingen, CH (1994)

Company Filing History:

goldMedal14 out of 1,603 
 
Sandoz Gmbh
 patents
silverMedal5 out of 832,761 
Other
 patents

Years Active: 1977-1994

Loading Chart...
19 patents (USPTO):Explore Patents
1. 5347050 - 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical (1994-09-13),
2. 4977153 - 3-aminopropyloxyphenyl derivatives, pharmaceutical compositions (1990-12-11),
3. 4970238 - 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical (1990-11-13),
4. 4816604 - 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical (1989-03-28),
5. 4661513 - 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical (1987-04-28),
6. 4510150 - Pharmaceutical compositions effective against coronary heart disease and (1985-04-09),
7. 4460586 - 2-Cyano-4-(2-hydroxy-3-substituted-aminopropoxy) indoles (1984-07-17),
8. 4425362 - 3-Aminopropoxyphenyl derivatives and pharmaceutical compositions (1984-01-10),
9. 4411913 - 8'-[(3-Amino-2-hydroxy-propoxy)]-spiro-[cyclopentane-1,2'(1 (1983-10-25),
10. 4361562 - 3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical (1982-11-30),
11. 4322437 - Spiro substituted indanones and tetralones (1982-03-30),
12. 4304915 - 3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical (1981-12-08),
13. 4235919 - 1-(Indol-4-yloxy)-3-(2-substituted amino)-2-propanols and pharmaceutical (1980-11-25),
14. 4137331 - 3-Piperidino-2-hydroxypropoxy substituted-2-indolinones (1979-01-30),
15. 4129658 - 4-Styryl-hexahydro-4-indolinols (1978-12-12),

Title: Richard Berthold: Innovator in Pharmaceutical Chemistry

Introduction

Richard Berthold is a notable inventor based in Bottmingen, Switzerland. With a remarkable portfolio of 19 patents, he has contributed significantly to the field of pharmaceutical chemistry, particularly in the development of innovative compounds with therapeutic potential.

Latest Patents

Berthold's recent patents include groundbreaking inventions focused on 3-aminopropoxyphenyl derivatives and their physiological applications. One of his patents describes compounds characterized by a hydroxy group in the 2 position of the 3-aminopropoxy side chain. These compounds are recognized for their utility as cardioselective β-adrenoceptor blocking agents, showcasing Berthold's commitment to advancing cardiac health solutions. Additionally, he has developed 3-aminopropyloxyphenyl derivatives that exhibit similar beta adrenoceptor blocking activity, outlined in his patent detailing various substituents and their pharmaceutical compositions.

Career Highlights

Throughout his career, Richard Berthold has made significant strides in pharmaceutical research and development. He has been affiliated with Sandoz GmbH, where he worked on innovative drug formulations and therapeutic agents. His expertise in synthesizing novel compounds has paved the way for advancements in cardio-related therapies.

Collaborations

Berthold has collaborated with esteemed professionals in the field, including William J. Louis and Andre Stoll. These partnerships have enabled him to leverage diverse expertise and insights, further enhancing the impact of his inventions in the pharmaceutical industry.

Conclusion

Richard Berthold stands out as a prominent figure in pharmaceutical innovation. His contributions, especially in the realm of β-adrenoceptor blocking agents, illustrate his profound impact on drug development and therapeutic applications. As he continues to expand his horizons in the world of chemistry, Berthold's work remains pivotal in shaping future medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…